8-11444139-G-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_053279.3(FAM167A):c.273C>A(p.His91Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000546 in 1,613,094 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_053279.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
FAM167A | NM_053279.3 | c.273C>A | p.His91Gln | missense_variant | 2/3 | ENST00000284486.9 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
FAM167A | ENST00000284486.9 | c.273C>A | p.His91Gln | missense_variant | 2/3 | 1 | NM_053279.3 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000328 AC: 50AN: 152210Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000770 AC: 19AN: 246660Hom.: 0 AF XY: 0.0000521 AC XY: 7AN XY: 134476
GnomAD4 exome AF: 0.0000260 AC: 38AN: 1460766Hom.: 0 Cov.: 33 AF XY: 0.0000193 AC XY: 14AN XY: 726700
GnomAD4 genome AF: 0.000328 AC: 50AN: 152328Hom.: 0 Cov.: 33 AF XY: 0.000282 AC XY: 21AN XY: 74480
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 19, 2022 | The c.273C>A (p.H91Q) alteration is located in exon 2 (coding exon 1) of the FAM167A gene. This alteration results from a C to A substitution at nucleotide position 273, causing the histidine (H) at amino acid position 91 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at